Psychemedics Corp
NASDAQ:PMD
Psychemedics Corp
Psychemedics Corp. engages in the provision of drug testing services through the analysis of hair samples. The company is headquartered in Acton, Massachusetts and currently employs 139 full-time employees. The firm provides testing services for the detection of drugs of abuse through the analysis of hair samples. The Company’s testing methods utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. The firm customize its enzyme immunoassay (EIA) procedures to drug test hair samples. The firm provides screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, phenylcyclohexyl piperidine (PCP), amphetamines, opiates, synthetic cannabinoids, benzodiazepines, nicotine and fentanyl. The firm markets its corporate drug testing services through its own sales force, distributors and webinars. The firm markets its home drug testing service, PDT-90, through the Internet.
Psychemedics Corp. engages in the provision of drug testing services through the analysis of hair samples. The company is headquartered in Acton, Massachusetts and currently employs 139 full-time employees. The firm provides testing services for the detection of drugs of abuse through the analysis of hair samples. The Company’s testing methods utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. The firm customize its enzyme immunoassay (EIA) procedures to drug test hair samples. The firm provides screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, phenylcyclohexyl piperidine (PCP), amphetamines, opiates, synthetic cannabinoids, benzodiazepines, nicotine and fentanyl. The firm markets its corporate drug testing services through its own sales force, distributors and webinars. The firm markets its home drug testing service, PDT-90, through the Internet.
